Transition From Intraoperative Vancomycin‐Piperacillin Tazobactam to Vancomycin‐Cefepime Does Not Change Acute Kidney Injury or Renal Recovery Outcomes in Patients Undergoing Heart Transplantation
Clinical Transplantation · 2025
DOI: 10.1111/ctr.70213 ↗At a glance
Journal article in Clinical Transplantation, 2025. Written by Ashley L Golbus and 8 co-authors. Institution: College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA. Major MEDLINE topics: Vancomycin, Acute Kidney Injury, Anti-Bacterial Agents, Heart Transplantation. 30 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: DCI, Duke Cancer Institute.
Abstract (original language)
Introduction
The impact of empiric intraoperative vancomycin and piperacillin‐tazobactam (VPT) compared to vancomycin and cefepime (VC) on AKI is equivocal, and renal recovery and infection outcomes have not been studied in this context. Further, this has not been studied in patients undergoing orthotopic heart transplantation (OHT).
Methods
We performed a single‐center prospective study in patients undergoing OHT ( n = 120), with a change in intraoperative microbial coverage from VPT to VC. Primary outcomes included AKI rates and stage. Secondary outcomes included renal recovery rates, bloodstream bacterial infections, rates of enterococcal infection, ESRD (end‐stage renal disease), change in eGFR, and mortality at 12 months post‐OHT.
Results
Rates of all stages of AKI were similar between groups ( p = 0.769), and the majority of AKI in both groups were Stage 1. 27.1% of patients in the pre‐intervention arm and 25.0% in the post‐intervention arm had a Stage 3 AKI ( p = 0.798). Rates of recovery from AKI at 7 days showed a trend toward improved recovery in patients receiving VC compared to VPT (65.1%, 46.7%, p = 0.056), but recovery from RRT at 7 days and recovery from RRT at hospital discharge were not statistically significant between groups ( p = 0.140, p = 0.659). Rates of bloodstream infection were similar following the change in empiric antimicrobials (2.08%, 4.17%; p = 0.53), and rates of wound infection were similar following this change (4.2%, 1.4%; p = 0.56). There was no increase in enterococcal infections.
Conclusion
In patients undergoing OHT and receiving empiric antimicrobial therapy, change from VPT to VC did not affect the incidence or severity of AKI, renal recovery, or infection rates.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
- Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
- School of Medicine, University College Dublin, Dublin, Ireland.
- Division of Cardiothoracic Surgery, Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
- Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
ORCID profiles: Ashley L Golbus, Courtney E Harris, Rupak Mukherjee
Funding
- DCI
- Duke Cancer Institute
Cite
APA
Golbus, A. L., Quadri, S., Park, E., Harris, C. E., Murray, P. T., Kilic, A., Tedford, R. J., Mukherjee, R., & McMahon, B. A. (2025). Transition From Intraoperative Vancomycin‐Piperacillin Tazobactam to Vancomycin‐Cefepime Does Not Change Acute Kidney Injury or Renal Recovery Outcomes in Patients Undergoing Heart Transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.70213
Vancouver
Golbus AL, Quadri S, Park E, Harris CE, Murray PT, Kilic A, et al. Transition From Intraoperative Vancomycin‐Piperacillin Tazobactam to Vancomycin‐Cefepime Does Not Change Acute Kidney Injury or Renal Recovery Outcomes in Patients Undergoing Heart Transplantation. Clinical Transplantation. 2025. doi:10.1111/ctr.70213
BibTeX
@article{Golbus2025,
author = {Golbus, Ashley L and Quadri, Syed and Park, Elaine and Harris, Courtney E and Murray, Patrick T and Kilic, Arman and Tedford, Ryan J and Mukherjee, Rupak and McMahon, Blaithin A},
title = {Transition From Intraoperative Vancomycin‐Piperacillin Tazobactam to Vancomycin‐Cefepime Does Not Change Acute Kidney Injury or Renal Recovery Outcomes in Patients Undergoing Heart Transplantation},
journal = {Clinical Transplantation},
year = {2025},
doi = {10.1111/ctr.70213}
}
EUVIMED